Compstatin control peptide (TFA)

Compstatin control peptide (TFA)

• UNSPSC Description: Compstatin control peptide TFA is a negative control of Compstatin (HY-P1036). Compstatin is a potent complement system C3 inhibitor[1].
• Target Antigen: Others
• Type: Peptides
• Related Pathways: Others
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/compstatin-control-peptide-tfa.html
• Solubility: H2O
• Smiles: OC(C(F)(F)F)=O.CC[C@H](C)[C@H](N)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@H](C(N)=O)[C@H](O)C)=O)=O)=O)CC1=CN=CN1)=O)CC2=CN=CN2)=O)=O)CC3=CNC4=CC=CC=C34)=O)=O)=O)=O)=O)=O
• Molecular Weight: 1488.65 (free base)
• References & Citations: [1]Sahu A, et al. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol. 2000 Sep 1;165(5):2491-9.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported